SCHEMBL30877338

SCHEMBL30877338

Cc1ccc(S(=O)(=O)n2cccc2C2=CCOCC2)cc1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RAPGEF4 Q8WZA2 1/20 0.47
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
HSD11B1 P28845 2/20 0.39
L3MBTL1 Q9Y468 3/20 0.38
KDM4E B2RXH2 1/20 0.38
UBE2N P61088 1/20 0.38
PKM P14618 2/20 0.37
GAA P10253 1/20 0.37
ACHE P22303 1/20 0.37
POLB P06746 2/20 0.36
HTT P42858 2/20 0.36
ALDH3A1 P30838 1/20 0.36
NOD1 Q9Y239 1/20 0.36
LMNA P02545 1/20 0.36
THRB P10828 1/20 0.36
MMP2 P08253 1/20 0.36
ALDH1A1 P00352 1/20 0.36
P2RX4 Q99571 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29179075 0.82 RAPGEF4 (0.49) RAPGEF4CA1CA2HSD11B1L3MBTL1
SCHEMBL30877344 0.81 PIK3CD (0.35) RAPGEF4CA1CA2HSD11B1PKM
SCHEMBL30877437 0.80 HTR6 (0.50) RAPGEF4CA1CA2HSD11B1PKM
SCHEMBL29806024 0.73 HTR6 (0.47) RAPGEF4CA1CA2HSD11B1
SCHEMBL25425550 0.72 RAPGEF4 (0.50) RAPGEF4CA1CA2L3MBTL1KDM4E
SCHEMBL7678499 0.72 RAPGEF4 (0.56) RAPGEF4CA1CA2HSD11B1L3MBTL1
SCHEMBL22128215 0.71 HTR6 (0.47) L3MBTL1
SCHEMBL3188642 0.70 RAPGEF4 (0.61) RAPGEF4CA1CA2L3MBTL1KDM4E
SCHEMBL1365792 0.70 RAPGEF4 (0.61) RAPGEF4CA1CA2L3MBTL1KDM4E
SCHEMBL3836392 0.69 RAPGEF4 (0.50) RAPGEF4CA1CA2L3MBTL1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4619402-A1 GPR17 MODULATORS AND USES THEREOF Myrobalan Therapeutics, Inc. (US) 2025-09-24 EP disclosed
CN-117964643-B Pyrrole [2,3-b ] pyridine derivative and preparation method and application thereof 苏州朗睿生物医药有限公司 2024-07-02 CN disclosed
WO-2024104462-A1 GPR17 MODULATORS AND USES THEREOF MYROBALAN THERAPEUTICS NANJING CO. LTD (CN) 2024-05-23 WO disclosed
CN-117964643-A Pyrrole [2,3-b ] pyridine derivative and preparation method and application thereof 苏州朗睿生物医药有限公司 2024-05-03 CN disclosed